• Decipher Biosciences Achieves Major Medicare Milestone for Decipher Prostate Genomic Tests

    9 days ago - By San Diego Biotechnology

    First Precision Oncology Company to Receive Medicare Coverage for Both Favorable and Unfavorable Intermediate Risk Prostate Cancer
    SAN DIEGO, Dec. 3, 2019 /PRNewswire/ - Decipher Biosciences, a leader in the field of urologic cancer genomics, today......
    Read more ...